Amlodipine/valsartan combination and amlodipine/valsartan/hydrochlorothiazide (Aml/Val/HCTZ) are agents approved for the treatment of hypertension in Pakistan since 2008 and 2011, respectively. Both have demonstrated their good tolerance and provision in clinical trials for effective BP lowering.
Side Effects:
- Swelling hands/ankles/feet
- Fainting
- Fast heartbeat
- Unusual change in the amount of urine
- Symptoms of a high potassium blood level (such as muscle weakness, slow/irregular heartbeat)
- Signs of infection (such as fever, chills, persistent sore throat)
Reviews
There are no reviews yet.